Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chelsea L. Carman"'
Autor:
Girja S. Shukla, Walter C. Olson, Stephanie C. Pero, Yu-jing Sun, Chelsea L. Carman, Craig L. Slingluff, David N. Krag
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Abstract Background Our research is focused on using the vaccine draining lymph node to better understand the immune response to cancer vaccines and as a possible source of anti-cancer reagents. We evaluated vaccine draining lymph nodes archived from
Externí odkaz:
https://doaj.org/article/94d536027ee0417ba05e947db001f987
Autor:
Giselle Saulnier Sholler, Ping Zhao, Girja S. Shukla, Yu-Jing Sun, Stephanie C. Pero, David N. Krag, Chelsea L. Carman
Publikováno v:
Journal of Immunological Methods. 426:35-41
Antibody therapy of neuroblastoma is promising and our goal is to derive antibodies from patients with neuroblastoma for developing new therapeutic antibodies. The feasibility of using residual bone marrow obtained for clinical indications as a sourc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab35d7c1bda029024164cffa12640ef4
https://doi.org/10.1016/j.jim.2015.07.009
https://doi.org/10.1016/j.jim.2015.07.009
Autor:
David N. Krag, Seth P. Harlow, Chelsea L. Carman, Yu-Jing Sun, Girja S. Shukla, Stephanie C. Pero
Publikováno v:
Journal of immunological methods. 455
Autoantibodies to breast and other cancers are commonly present in cancer patients. A method to rapidly produce these anti-cancer autoantibodies in the lab would be valuable for understanding immune events and to generate candidate reagents for thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b82c842e1acc7c7ec2445756da920e
https://pubmed.ncbi.nlm.nih.gov/29382466
https://pubmed.ncbi.nlm.nih.gov/29382466
Autor:
Chelsea L. Carman, Walter C. Olson, Stephanie C. Pero, Yu-Jing Sun, Craig L. Slingluff, David N. Krag, Girja S. Shukla
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-9 (2017)
Background Our research is focused on using the vaccine draining lymph node to better understand the immune response to cancer vaccines and as a possible source of anti-cancer reagents. We evaluated vaccine draining lymph nodes archived from a clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31cebaacc324cd9e8c2fded0c29af54a
https://doi.org/10.1186/s12967-017-1283-8
https://doi.org/10.1186/s12967-017-1283-8
Autor:
Thomas A. Roland, Chelsea L. Carman, David N. Krag, Laurence E. McCahill, Yu-Jing Sun, Elena Peletskaya, Girja S. Shukla, Stephanie C. Pero
Publikováno v:
Cancer Immunology, Immunotherapy. 62:1397-1410
Phage display is a powerful method for target discovery and selection of ligands for cancer treatment and diagnosis. Our goal was to select tumor-binding antibodies in cancer patients. Eligibility criteria included absence of preexisting anti-phage a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321cb25458e8c01bd1939af82e9a3ccf
https://doi.org/10.1007/s00262-013-1443-5
https://doi.org/10.1007/s00262-013-1443-5
Autor:
Yu-Jing Sun, Dimitry N. Krementsov, Chelsea L. Carman, David N. Krag, Stephanie C. Pero, Girja S. Shukla, Cory Teuscher, Christopher C. Krag
Publikováno v:
Vaccine. 35(9)
Purpose Our research is focused on using vaccine draining lymph nodes as a source of immune cells to better understand the immune response and to attempt to generate new anti-cancer reagents. Following a vaccine, harvesting the lymph node can only be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c458841f43b3e9e3a55446dee7e64d73
https://pubmed.ncbi.nlm.nih.gov/28161423
https://pubmed.ncbi.nlm.nih.gov/28161423
Autor:
David N. Krag, Chelsea L. Carman, Girja S. Shukla, Ping Zhao, Giselle Saulnier Sholler, Stephanie C. Pero, Yu-Jing Sun
Publikováno v:
Cancer Research. 76:581-581
Today antibody therapy is considered to be one of the most important and successful strategies to treat a variety of cancers. For example, the addition of antibodies such as Herceptin and Avastin to a chemotherapy regimen has shown improved survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fafbee540139ca75652e4a7ca43bacb1
https://doi.org/10.1158/1538-7445.am2016-581
https://doi.org/10.1158/1538-7445.am2016-581
Publikováno v:
Cancer Research. 75:5019-5019
Lymph nodes are one of the important sites in the body where immune responses to antigens are initiated. The tumor-draining lymph node or sentinel node is the first site where cancer cells and cancer-related antigens are most likely to spread. In res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48c7e6b77b4d7c0e03dad8f6ecb3df2c
https://doi.org/10.1158/1538-7445.am2015-5019
https://doi.org/10.1158/1538-7445.am2015-5019
Autor:
Girja S. Shukla, David N. Krag, Yu-Jing Sun, Stephanie C. Pero, Craig L. Slingluff, Walter C. Olson, Chelsea L. Carman
Publikováno v:
Cancer Research. 74:3638-3638
Human vaccine studies regularly demonstrate vaccine-induced antibodies in the blood. Characterization of these antibodies shows that they exhibit an extensive range of bioactive mechanisms. Unfortunately, there is not yet a reliable method by which t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f394e1041e6be102ff2e154b54926bd
https://doi.org/10.1158/1538-7445.am2014-3638
https://doi.org/10.1158/1538-7445.am2014-3638
Publikováno v:
Cancer Research. 73:4736-4736
The field of targeted therapy is providing an entirely new generation of highly active anticancer drugs. For example, addition of a targeted drug to a chemotherapy regimen has shown improved survival in the treatment of breast cancer (Herceptin) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d678a68c1b7412b1f1608779f002f122
https://doi.org/10.1158/1538-7445.am2013-4736
https://doi.org/10.1158/1538-7445.am2013-4736